These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1654288)

  • 1. Whole blood superoxide anion generation and efficiency of some erythrocyte antioxidant systems during recombinant human erythropoietin therapy of uremic anemia.
    Luciak M; Pawlicki L; Kedziora J; Trznadel K; Błaszczyk J; Buczyński A
    Free Radic Biol Med; 1991; 10(6):397-401. PubMed ID: 1654288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide anion generation and lipid peroxidation processes during hemodialysis with reused cuprophan dialyzers.
    Trznadel K; Luciak M; Pawlicki L; Kedziora J; Blaszczyk J; Buczyński A
    Free Radic Biol Med; 1990; 8(5):429-32. PubMed ID: 2174813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients.
    Trznadel K; Pawlicki L; Kedziora J; Luciak M; Błaszczyk J; Buczyński A
    Free Radic Biol Med; 1989; 6(4):393-7. PubMed ID: 2540072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free oxygen species metabolism during haemodialysis with different membranes.
    Luciak M; Trznadel K
    Nephrol Dial Transplant; 1991; 6 Suppl 3():66-70. PubMed ID: 1663602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis.
    Vanella A; Geremia E; Pinturo R; Tiriolo P; Liuzzo G; Tiriolo C; Custorella A; Condorelli G; Giglio A
    Acta Haematol; 1983; 70(5):312-5. PubMed ID: 6414225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients.
    Mimic-Oka J; Simic T; Djukanovic L
    Ren Fail; 2002 Jan; 24(1):77-87. PubMed ID: 11921701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some indices of peripheral blood oxidative metabolism during acetate and bicarbonate hemodialysis in patients with chronic uremia].
    Sowińska-Pik V; Luciak M; Kedziora J; Trznadel K; Pawlicki L; Błaszczyk J; Sibińska E
    Pol Arch Med Wewn; 1994; 92 Spec No():37-42. PubMed ID: 7731898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment.
    Boran M; Küçükaksu C; Balk M; Cetin S
    Int Urol Nephrol; 1998; 30(4):507-12. PubMed ID: 9821056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin.
    Cavdar C; Camsari T; Semin I; Gönenc S; Acikgöz O
    Scand J Urol Nephrol; 1997 Aug; 31(4):371-5. PubMed ID: 9290168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants.
    Akisu M; Tuzun S; Arslanoglu S; Yalaz M; Kultursay N
    Acta Med Okayama; 2001 Dec; 55(6):357-62. PubMed ID: 11779098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis.
    Fontanellas A; Herrero JA; Coronel F; Santos JL; Morán MJ; Barrientos A; Enríquez de Salamanca R
    J Am Soc Nephrol; 1996 May; 7(5):774-9. PubMed ID: 8738813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis.
    Chen MF; Chang CL; Liou SY
    Blood Purif; 1998; 16(5):290-300. PubMed ID: 9917538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron.
    Delmas-Beauvieux MC; Combe C; Peuchant E; Carbonneau MA; Dubourg L; de Précigout V; Aparicio M; Clerc M
    Nephron; 1995; 69(4):404-10. PubMed ID: 7777104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
    Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
    Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell cation transports in uraemic anaemia: evidence for an increased K/Cl co-transport activity. Effects of dialysis and erythropoietin treatment.
    De Franceschi L; Olivieri O; Girelli D; Lupo A; Bernich P; Corrocher R
    Eur J Clin Invest; 1995 Oct; 25(10):762-8. PubMed ID: 8557063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin.
    Brunati C; Cappellini MD; De Feo T; Guastoni C; Ballerini L; Busnach G; Civati G; Fiorelli G; Minetti L
    Am J Nephrol; 1992; 12(1-2):9-13. PubMed ID: 1415372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between erythrocyte superoxide dismutase activity and plasma levels of some trace elements (Al, Cu, Zn) of dialysis patients.
    Hasanoğlu E; Altan N; Sindel S; Ongun CO; Bali M; Altintaş E
    Gen Pharmacol; 1994 Jan; 25(1):107-10. PubMed ID: 8026695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte vitamins B1, B2 and B6 and erythropoietin.
    Mydlik M; Derzsiová K
    Am J Nephrol; 1993; 13(6):464-6. PubMed ID: 8141181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.